Trial intelligence / Profile preview

Acute Metabolic Effects of Melatonin Treatment

NCT03204877Phase 2Completed

Sponsor
Aarhus University
Start
Aug 2017
Primary completion
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of melatonin in type 2 diabetes mellitus (T2DM), sponsored by Aarhus University. Started Aug 2017; status: completed.

02

Drugs

melatonin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT03204877.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03204877.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call